4.7 Article

Short telomeres: from dyskeratosis congenita to sporadic aplastic anemia and malignancy

期刊

TRANSLATIONAL RESEARCH
卷 162, 期 6, 页码 353-363

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.trsl.2013.05.003

关键词

-

资金

  1. National Cancer Institute [1K23CA158148-01A1]
  2. Cancer Prevention Research Institute of Texas [RP120076]

向作者/读者索取更多资源

Telomeres are DNA-protein structures that form a protective cap on chromosome ends. As such, they prevent the natural ends of linear chromosomes from being subjected to DNA repair activities that would result in telomere fusion, degradation, or recombination. Both the DNA and protein components of the telomere are required for this essential function, because insufficient telomeric DNA length, loss of the terminal telomeric DNA structure, or deficiency of key telomere-associated factors may elicit a DNA damage response and result in cellular senescence or apoptosis. In the setting of failed checkpoint mechanisms, such DNA-protein defects can also lead to genomic instability through telomere fusions or recombination. Thus, as shown in both model systems and in humans, defects in telomere biology are implicated in cellular and organismal aging as well as in tumorigenesis. Bone marrow failure and malignancy are 2 life-threatening disease manifestations in the inherited telomere biology disorder dyskeratosis congenita. We provide an overview of basic telomere structure and maintenance. We outline the telomere biology defects observed in dyskeratosis congenita, focusing on recent discoveries in this field. Last, we review the evidence of how telomere biology may impact sporadic aplastic anemia and the risk for various cancers.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Oncology

Clinical and functional characterization of telomerase variants in patients with pediatric acute myeloid leukemia/myelodysplastic syndrome

Christopher G. Tomlinson, Ghadir Sasa, Geraldine Aubert, Bailey Martin-Giacalone, Sharon E. Plon, Tracy M. Bryan, Alison A. Bertuch, Maria M. Gramatges

LEUKEMIA (2021)

Article Oncology

Identifying relapses and stem cell transplants in pediatric acute lymphoblastic leukemia using administrative data: Capturing national outcomes irrespective of trial enrollment

Viviane C. Cahen, Yimei Li, Kelly D. Getz, Caitlin W. Elgarten, Amanda M. DiNofia, Jennifer J. Wilkes, Lena E. Winestone, Yuan-Shung Huang, Tamara P. Miller, M. Monica Gramatges, Karen R. Rabin, Brian T. Fisher, Richard Aplenc, Alix E. Seif

Summary: This study focused on accurately identifying and evaluating relapse and hematopoietic stem cell transplantation (HSCT) occurrences in children with acute lymphoblastic leukemia (ALL) using administrative data. By utilizing the PHIS database and chart reviews at two hospitals, the study demonstrated that the method was effective in identifying relapse and HSCT, while also estimating their incidences.

PEDIATRIC BLOOD & CANCER (2021)

Article Pediatrics

Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders

Ryan W. Himes, Eric H. Chiou, Karen Queliza, Dror S. Shouval, Raz Somech, Suneet Agarwal, Kunal Jajoo, David S. Ziegler, Christian P. Kratz, James Huang, Tiffany L. Lucas, Kasiani C. Myers, Adam S. Nelson, Courtney D. DiNardo, Blanche P. Alter, Neelam Giri, Payal P. Khincha, Lisa J. McReynolds, Carlo Dufour, Filomena Pierri, Frederick D. Goldman, Youmna Sherif, Sharon A. Savage, Tamir Miloh, Alison A. Bertuch

Summary: Gastrointestinal hemorrhage in patients with telomere biology disorders is associated with significant morbidity, with vascular ectasias rather than varices being common, and the overall long-term outcome for affected patients is poor.

JOURNAL OF PEDIATRICS (2021)

Article Multidisciplinary Sciences

Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

Alyssa L. Kennedy, Kasiani C. Myers, James Bowman, Christopher J. Gibson, Nicholas D. Camarda, Elissa Furutani, Gwen M. Muscato, Robert H. Klein, Kaitlyn Ballotti, Shanshan Liu, Chad E. Harris, Ashley Galvin, Maggie Malsch, David Dale, John M. Gansner, Taizo A. Nakano, Alison Bertuch, Adrianna Vlachos, Jeffrey M. Lipton, Paul Castillo, James Connelly, Jane Churpek, John R. Edwards, Nobuko Hijiya, Richard H. Ho, Inga Hofmann, James N. Huang, Sioban Keel, Adam Lamble, Bonnie W. Lau, Maxim Norkin, Elliot Stieglitz, Wendy Stock, Kelly Walkovich, Steffen Boettcher, Christian Brendel, Mark D. Fleming, Stella M. Davies, Edie A. Weller, Christopher Bahl, Scott L. Carter, Akiko Shimamura, R. Coleman Lindsley

Summary: Research on germline genetic leukemia predisposition in Shwachman-Diamond syndrome identified early emergence of multiple hematopoietic clones with EIF6 or TP53 mutations. The germline SBDS deficiency constrains clone selection via compensatory EIF6 inactivation and maladaptive TP53 mutations, with subsequent leukemia linked to biallelic TP53 alterations. These findings offer insights into clinical surveillance strategies.

NATURE COMMUNICATIONS (2021)

Article Hematology

Hematologic complications with age in Shwachman-Diamond syndrome

Elissa Furutani, Shanshan Liu, Ashley Galvin, Sarah Steltz, Maggie M. Malsch, Sara K. Loveless, Leann Mount, Jordan H. Larson, Kelan Queenan, Alison A. Bertuch, Mark D. Fleming, John M. Gansner, Amy E. Geddis, Rabi Hanna, Sioban B. Keel, Bonnie W. Lau, Jeffrey M. Lipton, Robert Lorsbach, Taizo A. Nakano, Adrianna Vlachos, Winfred C. Wang, Stella M. Davies, Edie Weller, Kasiani C. Myers, Akiko Shimamura

Summary: The study examined 153 subjects with SDS and found that absolute neutrophil counts and hemoglobin levels increase with age, while platelet counts and marrow cellularity decrease. Marrow cellularity was not correlated with blood counts. 17% of subjects developed myeloid malignancies.

BLOOD ADVANCES (2022)

Article Genetics & Heredity

The germline p53 activation syndrome: A new patient further refines the clinical phenotype

Runjun D. Kumar, Mustafa Tosur, Seema R. Lalani, Donald H. Mahoney, Alison A. Bertuch

Summary: This study reports a patient with red cell aplasia, intellectual disability, and other symptoms, who carries a germline variation in the TP53 gene that can activate the transcription factor. This case adds to the understanding of the clinical disease associated with such variations.

AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2022)

Article Hematology

Editing TINF2 as a potential therapeutic approach to restore telomere length in dyskeratosis congenita

Seunga Choo, Franziska K. Lorbeer, Samuel G. Regalado, Sarah B. Short, Shannon Wu, Gabrielle Rieser, Alison A. Bertuch, Dirk Hockemeyer

Summary: Mutations in the TINF2 gene cause telomere shortening and BM failure syndrome. This study introduces TIN2-DC mutations in hESCs and HSPCs to understand the disease mechanism and develop therapeutic strategies. The study demonstrates that editing the mutant TINF2 allele restores telomere length and replicative potential in stem cells. The findings provide a versatile platform for evaluating potential therapeutic approaches for BM failure.
Article Oncology

Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia

Priyadarshani Dharia, Michael D. Swartz, M. Brooke Bernhardt, Han Chen, M. Monica Gramatges, Philip J. Lupo, Austin L. Brown, Michael E. Scheurer

Summary: This study retrospectively analyzed 548 patients with acute lymphoblastic leukemia and found that older age, overweight, and treatment intensity increased the risk of pegaspargase-associated toxicities.

LEUKEMIA & LYMPHOMA (2022)

Article Oncology

Distribution and frequency of tyrosine kinase inhibitor-associated long-term complications in children with chronic myeloid leukemia

Elizabeth E. Dong, Michael A. Bruno, Jeffrey J. Kim, Melanie B. Bernhardt, Austin L. Brown, Maria M. Gramatges

Summary: Tyrosine kinase inhibitors (TKIs) have improved prognosis for pediatric leukemia, but this study suggests that TKI exposure may lead to late-onset complications. The results indicate that children receiving TKI treatment may face long-term health risks.

PEDIATRIC BLOOD & CANCER (2022)

Article Oncology

Epigenetic age acceleration among survivors of pediatric medulloblastoma and primitive neuroectodermal tumor

Rachel D. Harris, Melissa A. Richard, Maria Monica J. Gramatges, Kevin Wilhelm, Michael E. Scheurer, Philip J. Lupo, Austin L. Brown

Summary: Survivors of childhood central nervous system tumors may experience early-onset aging-related phenotypes. DNA methylation age, as an emerging biomarker, can predict the chronic health conditions of long-term survivors. This study explores the epigenetic age acceleration in survivors of pediatric CNS tumors using blood samples collected post-diagnosis.

PEDIATRIC HEMATOLOGY AND ONCOLOGY (2023)

Review Genetics & Heredity

Genetics of human telomere biology disorders

Patrick Revy, Caroline Kannengiesser, Alison A. Bertuch

Summary: This article reviews the confirmed and potential genes causing telomere diseases and describes their main functions in telomere biology. The authors also discuss the genetic features underlying the complexity of these diseases.

NATURE REVIEWS GENETICS (2023)

Article Medicine, Research & Experimental

Pathogenicity and impact of HLA class I alleles in aplastic anemia patients of different ethnicities

Timothy S. Olson, Benjamin F. Frost, Jamie L. Duke, Marian Dribus, Hongbo M. Xie, Zachary D. Prudowsky, Elissa Furutani, Jonas Gudera, Yash B. Shah, Deborah Ferriola, Amalia Dinou, Ioanna Pagkrati, Soyoung Kim, Yixi Xu, Meilun He, Shannon Zheng, Sally Nijim, Ping Lin, Chong Xu, Taizo A. Nakano, Joseph H. Oved, Beatriz M. Carreno, Yung-Tsi Bolon, Shahinaz M. Gadalla, Steven Ge Marsh, Sophie Paczesny, Stephanie J. Lee, Dimitrios S. Monos, Akiko Shimamura, Alison A. Bertuch, Loren Gragert, Stephen R. Spellman, Daria Babushok

Summary: This study evaluated somatic HLA loss in patients with acquired aplastic anemia (AA) and identified HLA alleles associated with the development of AA. The results showed that HLA alleles increase the risk of AA, but do not affect response to immunosuppression or transplant outcomes. Higher pathogenicity alleles are associated with higher rates of clonal evolution in AA patients.

JCI INSIGHT (2022)

Editorial Material Hematology

Poverty and health equity in childhood leukemia

Maria Monica Gramatges

Article Oncology

Germline Genetic and Treatment-Related Risk Factors for Diabetes Mellitus in Survivors of Childhood Cancer: A Report From the Childhood Cancer Survivor Study and St Jude Lifetime Cohorts

Melissa A. Richard, Sogol Mostoufi-Moab, Nisha Rathore, Jessica Baedke, Austin L. Brown, Stephen J. Chanock, Danielle N. Friedman, Monica Gramatges, Rebecca M. Howell, Kala Y. Kamdar, Wendy M. Leisenring, Lillian R. Meacham, Lindsay M. Morton, Kevin Oeffinger, Leslie L. Robison, Yadav Sapkota, Charles A. Sklar, Gregory T. Armstrong, Smita Bhatia, Philip J. Lupo

Summary: This study aimed to evaluate the genetic risk factors of diabetes mellitus among childhood cancer survivors. A novel diabetes locus was identified among survivors not exposed to abdominal radiation. Risk prediction models showed moderate accuracy in predicting diabetes among survivors.

JCO PRECISION ONCOLOGY (2022)

暂无数据